About NV Therapeutics
NV Therapeutics is a private company based in Berkeley, California, incorporated in 2024 in Delaware. It has reported $3,000,000 raised in one offering on Form D since March 2025. Its chief executive is Kevin Holden.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 13, 2024 | Mar 14, 2025 | $3,000,000of $7.5M target | 1 | $3.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NV Therapeutics's Form D filed Mar 14, 2025.
AK
Audrey Kozlov
Director
DD
Daniel Dever
Director
KH
Kevin Holden
Chief Executive Officer and director
DK
Dmitry Kuzmin
Director